Impact of allergic rhinitis symptoms on quality of life in primary care.
about
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the USMonitoring Allergen Immunotherapy Effects by MicroarrayAllergen Immunotherapy (AIT): a prototype of Precision MedicineBurden of allergic respiratory disease: a systematic reviewMite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cyclePilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.Correlations of nasal responses to leukotriene D4 and histamine nasal provocation with quality of life in allergic rhinitis.An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panelAllergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history.Catching allergy by a simple questionnaireA common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patientsThe hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey.Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational studyReduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy.MP29-02: a breakthrough for the treatment of allergic rhinitis.Indications for surgery in refractory rhinitis.Current recommendations and emerging options for the treatment of allergic rhinitis.Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.The clinical significance of the pollen calendar of the Western Thrace/northeast Greece region in allergic rhinitis.MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.Current controversies and challenges in allergic rhinitis management.Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.Escaping the trap of allergic rhinitis.Comparison of outcome measures in allergic rhinitis in children, adolescents and adults.Spatiotemporal monitoring of allergic rhinitis symptoms in The Netherlands using citizen science.Need for medication and stuffy nose predict the severity of allergic rhinitis.Quality of Life in Pediatric Patients with Allergic Rhinitis treated at the Medical Clinic of Integrated Education - Unisul.Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-lifeSymptomatology Patterns in Children with Allergic Rhinitis.A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone.Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.Measuring the perception of symptom, drug use and allergen immunotherapy efficacy using the Visual Analogue Scale.A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch.Management of allergic rhinitis in the era of effective over-the-counter treatments.
P2860
Q26741159-8FFF6131-5314-4538-8431-45850056B119Q26743503-3AD2D61A-2091-48A7-9241-A9D6F04FDEFAQ26776512-D0325D66-85F2-43E3-909B-E5D1B34DE864Q28079329-C7821E2A-6937-430E-AC5D-B98ACC7D830CQ28082353-AEAB41A5-B076-47AE-A744-78328B435466Q28355722-78B54658-732A-4CB9-A2A1-7B6A2B9CB188Q30239093-9A433E2C-AF48-4727-921E-A7F64DCE234DQ30370824-8721BE35-5737-4A3E-83E4-AB46F7431C28Q33697668-5A87F80A-B3FD-4971-8EB9-EB64105D0E58Q34661107-2A33982E-26EF-48CB-B78E-274BD1B35B4EQ35730145-26A15025-AA7E-443F-BDAB-70958F5EFE68Q36211005-4CEE94F5-D8C7-4414-B3B5-6BA6E04A4832Q36238142-152312E5-CDE1-4A55-B23D-540C216B6C2CQ36294156-1856E349-5FC2-4A9F-A48E-69D457564C7DQ36715163-DC3E8C08-EA92-476C-BA02-5A88FCD67F76Q37031239-2E37B535-6D8B-4CD2-9E76-34018C71297BQ37169911-FFAA45FE-3635-4B67-B26A-ED845484A688Q38131527-255E0063-BFDF-4D01-A504-D28B5AAD96E4Q38177219-CC672BF4-25E7-469A-916B-9E668251D30CQ38250070-578E4303-A0AB-47BA-8317-39D5C42F3921Q38369307-70C3F08B-D2C4-41E7-9379-501172FAFCB7Q38401392-07654F10-2337-4636-B76D-A0A27E791AFBQ38413189-51ECDC1C-8484-4FC3-A8FA-DE44C5A80BCBQ38543189-7C16AD91-6B98-466D-9A4A-10C2D696FD89Q38577949-C162415B-2EF0-4687-AB22-83ED1DCB3B9EQ38631412-83F6B2FF-E6F9-45A5-AE45-4149F7C0D15DQ38637608-282E6EDB-BCEA-4F28-AFC4-C60B8D60B04EQ38721025-063B9C26-95E8-48A3-9DC7-D3A51972006EQ39185309-BAD52FD2-6129-4D24-BD3B-9C8F20F10B2FQ39942966-04E90889-09AE-4D6A-89DC-E6E865AB0263Q40205077-AE75DF36-7B6E-4EBA-A234-2FF2A0400789Q40790263-95ED5B05-4783-46F9-9667-5506B675B465Q42277691-F7FC76DC-6309-4C1F-B725-E14A4242AF3BQ42368155-264C982D-032E-49C5-90A9-BD47B06B154FQ42638729-F07C811F-77C0-4C19-8158-0003B6AB31D2Q43488106-F99B82AE-2AC5-4F17-9A95-396CC485720EQ44800324-14B6BF51-2D02-4E4F-85C2-CC83A278B532Q45718503-4492398A-DE15-403A-85D6-7091E3954072Q45895483-3AE079C4-FCC6-4F8D-A32B-B23F99A965D7Q46267822-78C2C8A9-2142-4011-AFAF-B399B52385C4
P2860
Impact of allergic rhinitis symptoms on quality of life in primary care.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Impact of allergic rhinitis symptoms on quality of life in primary care.
@en
Impact of allergic rhinitis symptoms on quality of life in primary care.
@nl
type
label
Impact of allergic rhinitis symptoms on quality of life in primary care.
@en
Impact of allergic rhinitis symptoms on quality of life in primary care.
@nl
prefLabel
Impact of allergic rhinitis symptoms on quality of life in primary care.
@en
Impact of allergic rhinitis symptoms on quality of life in primary care.
@nl
P2093
P2860
P356
P1476
Impact of allergic rhinitis symptoms on quality of life in primary care.
@en
P2093
Jean Bousquet
Kamal Mesbah
Pascal Demoly
Philippe Devillier
P2860
P304
P356
10.1159/000342991
P577
2012-11-23T00:00:00Z